Combination of Sorafenib and Omacetaxine Mepesuccinate in Newly Diagnosed or Relapsed/Refractory AML Carrying FLT3-ITD
Phase 2
Completed
- Conditions
- AMLFLT3-ITD Mutation
- Interventions
- Drug: Omacetaxine Mepesuccinate Injection
- First Posted Date
- 2017-05-31
- Last Posted Date
- 2020-03-30
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 5
- Registration Number
- NCT03170895
- Locations
- 🇭🇰
The University of Hong Kong, Hong Kong, Hong Kong
Clinical and Genomic Registry of MDS in Asia
Recruiting
- Conditions
- Myelodysplastic Syndromes
- First Posted Date
- 2017-05-30
- Last Posted Date
- 2022-10-04
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 2600
- Registration Number
- NCT03169296
- Locations
- 🇭🇰
Department of Medicine, the University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong
Remote Ischaemic Preconditioning in Childhood Cancer
Not Applicable
Completed
- Conditions
- Cardiotoxicity
- Interventions
- Procedure: Remote Ischaemic PreconditioningOther: Control
- First Posted Date
- 2017-05-25
- Last Posted Date
- 2022-06-08
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 68
- Registration Number
- NCT03166813
- Locations
- 🇭🇰
Hong Kong Children's Hospital, Hong Kong, Hong Kong
The Feasibility and Safety of the TOETVA for Benign Thyroid Nodules
Not Applicable
Completed
- Conditions
- Thyroid Diseases
- Interventions
- Procedure: Transoral endoscopic thyroidectomy vestibular approach
- First Posted Date
- 2017-05-18
- Last Posted Date
- 2021-04-28
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 10
- Registration Number
- NCT03158961
- Locations
- 🇭🇰
Queen Mary Hospital, Hong Kong, Hong Kong
Optimizing HBV Management During Anti-CD20 Antibodies
Completed
- Conditions
- Liver DysfunctionImmune SuppressionHepatitis B
- Interventions
- Drug: Anti-CD20 antibody
- First Posted Date
- 2017-05-16
- Last Posted Date
- 2018-05-04
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 83
- Registration Number
- NCT03155984
- Locations
- 🇭🇰
The University of Hong Kong, Hong Kong, Hong Kong
Study of Xeloxiri Regimen for Patients With Refractory Metastatic Colorectal Cancer
Phase 2
Completed
- Conditions
- Colorectal Cancer
- Interventions
- First Posted Date
- 2017-05-09
- Last Posted Date
- 2017-05-09
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 32
- Registration Number
- NCT03146377
- Locations
- 🇭🇰
Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong
Training Program for Community Health Campaign: Fitter Families Project
Not Applicable
Completed
- Conditions
- Motor Activity
- Interventions
- Behavioral: Training group
- First Posted Date
- 2017-05-09
- Last Posted Date
- 2018-05-14
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 28
- Registration Number
- NCT03146169
- Locations
- 🇭🇰
Christian Family Service Centre, Kwun Tong, Hong Kong
Smoking Cessation Programme in Workplaces in Hong Kong (Phase III)
Not Applicable
Completed
- Conditions
- Smoking Cessation
- Interventions
- Behavioral: Health talk plus intensive social media interventionBehavioral: Health talk plus less intensive social media intervention
- First Posted Date
- 2017-05-05
- Last Posted Date
- 2021-09-21
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 679
- Registration Number
- NCT03142555
- Locations
- 🇭🇰
School of Nursing, The University of Hong Kong, Hong Kong, Hong Kong
Combination of Quizartinib and Omacetaxine Mepesuccinate for AML Carrying FLT3-ITD
Phase 2
- Conditions
- FLT3-ITD MutationAML
- Interventions
- Drug: Omacetaxine Mepesuccinate Injection
- First Posted Date
- 2017-05-01
- Last Posted Date
- 2020-12-10
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 40
- Registration Number
- NCT03135054
- Locations
- 🇭🇰
The University of Hong Kong, Hong Kong, Hong Kong
Cessation of Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myelogenous Leukaemia
- Conditions
- Leukemia, Myelogenous, Chronic Phase
- First Posted Date
- 2017-04-27
- Last Posted Date
- 2018-06-11
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 30
- Registration Number
- NCT03131986
- Locations
- 🇭🇰
The University of Hong Kong, Hong Kong, Hong Kong
© Copyright 2025. All Rights Reserved by MedPath